Understanding chronic inflammatory systemic diseases and their treatments
Evolution and Treatments of Chronic Inflammatory Systemic Diseases: Implementation of a Hospital Cohort in the Gastroenterology, Dermatology and Rheumatology Departments of the University Hospital of Besançon
This study looks at patients with chronic inflammatory diseases to see how these conditions are related and how they can be treated better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Besancon Academic / other |
| Locations | 1 site (Besançon) |
| Trial ID | NCT04191395 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with chronic inflammatory diseases, including inflammatory bowel diseases, rheumatoid arthritis, and chronic inflammatory skin diseases. It aims to explore the physiopathological, epidemiological, and therapeutic aspects of these conditions, particularly the associations between different inflammatory diseases. The study will collect data from patients treated at the gastroenterology, rheumatology, and dermatology departments of Besançon University Hospital to create a comprehensive database for chronic systemic inflammatory diseases.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with inflammatory bowel diseases, rheumatoid arthritis, spondyloarthritis, or chronic inflammatory skin diseases being treated at the University Hospital of Besançon.
Not a fit: Patients in emergency situations, those who oppose participation, or individuals who are minors or under legal protection may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of chronic inflammatory diseases, potentially enhancing patient outcomes.
How similar studies have performed: While this study addresses a common issue in chronic inflammatory diseases, it is novel in its approach to creating a unified database for these conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients treated for IBD (MC, UC or indeterminate colitis) in the gastroenterology department of Besançon University Hospital * Subject meeting the clinical, morphological and histological diagnostic criteria for MC, UC or indeterminate colitis or * Patients treated for chronic inflammatory rheumatism (RA, SpA, PsA) in the rheumatology department of the University Hospital of Besançon Subject meeting the ACR 2010 classification criteria of RA or modified New York criteria of Ankylosing spondylitis or ASAS criteria of axial or peripheral SpA or CASPAR criteria of PsA or * Patients treated for chronic inflammatory skin disease (Psoriasis, Verneuil's disease) in the dermatology department of the University Hospital of Besançon Exclusion Criteria: * Opposition of the patient * Patients in emergency situation, persons deprived of their liberty, protected minors or adults.
Where this trial is running
Besançon
- CHU Besançon — Besançon, France (Recruiting)
Study contacts
- Principal investigator: Clément Prati, Prof. — CHU Besançon
- Study coordinator: Charline Vauchy, PhD
- Email: cvauchy@chu-besancon.fr
- Phone: 0381218875
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.